Intuitive Surgical Inc’s recent filing unveils that its Officer ROBERT DESANTIS acquired Company’s shares for reported $0.13 million on Jun 10 ’25. In the deal valued at $525.81 per share,240 shares were bought.
Then, Brosius Mark sold 216 shares, generating $121,632 in total proceeds. Upon selling the shares at $563.11, the SVP & Chief Mfg and Supply Cha now owns 907 shares.
Before that, Brosius Mark sold 215 shares. Intuitive Surgical Inc shares valued at $120,551 were divested by the SVP & Chief Mfg and Supply Cha at a price of $560.70 per share. As a result of the transaction, Brosius Mark now holds 1,123 shares, worth roughly $0.58 million.
Deutsche Bank downgraded its Intuitive Surgical Inc [ISRG] rating to a Sell from a a Hold in a research note published recently. A number of analysts have revised their coverage, including Erste Group’s analysts, who increased its forecast for the stock in early June from “a Hold” to “a Buy”. Morgan Stanley also remained covering ISRG and has increased its forecast on December 02, 2024 with a “an Overweight” recommendation from previously “an Equal-weight” rating. Redburn Atlantic revised its rating on August 02, 2024. It rated ISRG as “a Buy” which previously was an “a Neutral”.
Price Performance Review of ISRG
On Monday, Intuitive Surgical Inc [NASDAQ:ISRG] saw its stock jump 1.34% to $519.04. Over the last five days, the stock has lost -1.35%. Intuitive Surgical Inc shares have fallen nearly -0.56% since the year began. Nevertheless, the stocks have risen 21.24% over the past one year. While a 52-week high of $616.00 was reached on 01/23/25, a 52-week low of $413.82 was recorded on 04/07/25.
Levels Of Support And Resistance For ISRG Stock
The 24-hour chart illustrates a support level at 514.18, which if violated will result in even more drops to 509.33. On the upside, there is a resistance level at 523.71. A further resistance level may holdings at 528.39.
The most recent change occurred on July 10, 2024 when Citigroup resumed its ‘”a Buy”‘ rating for the stock and retained the price target to $512.
